43 ceasefire violations reported in Syria in 24 hours ― Russian Defense MinistryWorld December 08, 1:16
One reconciliation agreement signed in Syria in 24 hours ― Russian Defense MinistryWorld December 08, 0:26
Lavrov confirms to Kerry Russia backs US proposal on Aleppo from December 2Russian Politics & Diplomacy December 07, 23:57
Russia has never imposed its decisions on Syria, Assad saysWorld December 07, 23:45
Rosneft privatization deal is completed — KremlinBusiness & Economy December 07, 21:06
Contact Group focuses on demining, creation of new security zones in Donbass — OSCE envoyWorld December 07, 20:57
Russian Defense Ministry reports 70% of eastern Aleppo under control of Syrian armyWorld December 07, 20:21
Moscow slams Polish FM's remarks on NATO-Russia Council meeting — sourceRussian Politics & Diplomacy December 07, 20:12
IOC extends doping-related sanctions against RussiaSport December 07, 19:35
GENEVA, October 3. /TASS/. The Court of Arbitration for Sport (CAS) is set to announce a decision on the appeal of Russian tennis star Maria Sharapova, submitted in summer against her two-year ban, on Tuesday, October 4, the court said in its statement on Monday.
"Decision in the case of Maria Sharapova v. International Tennis Federation to be released at 3.00 pm (Swiss time) on 4 October 2016," the statement said.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was imposed on June 8 by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations.
Due to the imposed ban world’s former No. 1 Sharapova had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.